I had an MRI of the brain and a cat scan of my lungs and abdominal area to determine if the clinical trial of medicine I have been taking the last three weeks is working.
I will see the doctor on Wednesday June 8th for the results.
I would like to take this opportunity to thank all my family and friends for their unending support, encouragement and love
It really helps me to know that you are thinking of me and praying for me.
Keep it up!
Thinking of you often, and scouring the scientific literature ...
ReplyDeleteLove you,
Diana
Thanks. Again.
ReplyDeleteDaily tefillos and Tehillim are being said for you, babe. I KNOW that day will be a very mazel-dik day, because my newest grandnephew's bris is that morning in Yerushalayim! So it HAS to be a good mazel day for you, too!!!
ReplyDeleteDaily tefillos and Tehillim are being said for you, babe. I KNOW that day will be a very mazel-dik day, because my newest grandnephew's bris is that morning in Yerushalayim! So it HAS to be a good mazel day for you, too!!!
ReplyDeleteMore for your consideration (and for your doctors):
ReplyDeletehttp://www.nbcnews.com/health/cancer/lung-cancer-trial-stopped-after-jimmy-carter-drug-stops-tumors-n593726
This is Keytruda, the same type of immunotherapy as Opdivo (anti-PD1 antibody).
Opdivo doesn't require "PD-L1 testing or a specific level, while Keytruda’s approval is for only patients with PD-L1 expression (technically >50% expression, the high level seen in about 25-30% of NSCLC patients, though it also has (somewhat less) activity in patients with ANY degree of PD-L1 expression, which gets up to 70-75% of NSCLC patients)."
http://cancergrace.org/lung/2016/06/16/keynote24pressrelease/#more-17314
So much more hope than even just a couple of years ago.
Love, Diana